Page 3 of Sanofi News
First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic countries…
To develop immuno-oncology pills Sanofi is teaming up with Germany’s Evotec and Austrian biotech firm Apeiron Biologics to develop a…
He will take the position as Executive Vice President and External Affairs Sanofi appointed Suresh Kumar as a new member…
Patent applications for pain treatments between 2008 and 2012 were dominated by Big Pharma, including Sanofi, Novartis and Merck &…
Both Apollo and Sanofi would endeavour to expand Apollo Sugar to provide superior value to patients and doctors with an…
Apollo Hospitals intends to launch 500 Apollo Sugar Clinics by 2019-end in India and overseas to spread network of diabetes…
In September this year, Apollo Hospitals and Sanofi joined hands to set up Sugar Clinics for diabetics. With 65 million…
The launch of Shan5 vaccine receives pre-qualification status from the World Health Organization
Drugmaker Sanofi Pasteur has announced the world’s first dengue vaccine could come in the second half of 2015.
Dengue has been a serious challenge to public health as it affects lakhs of people annually in India.